Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples